Machine learning specialist Intellegens and engineering simulation leader Ansys have announced a collaboration to integrate machine learning methods into Additive Manufacturing (AM) workflows, accelerating the development of reliable and repeatable AM processes.
Intellegens
Our mission is to help clients accelerate innovation by using our unique deep learning solutions to extract valuable information from existing processes and data.
Our technology originated from the work of Dr Gareth Conduit and collaborators at the Cavendish Laboratory, University of Cambridge. At Intellegens, we have further developed this work to build a unique Artificial Intelligence (AI) toolset that can train deep neural networks from sparse or noisy data.
Telephone: +44 (0)7810 303 762
Address :
Eagle Labs 28 Chesterton Road Cambridge
Post Code: CB4 3AZ
Country: United Kingdom
Website: http://intellegens.ai
Membership Type: Professional Individual and Corporate <5
Intellegens is a provider of specialist Artificial Intelligence (AI) algorithms, with a unique capability to exploit fragmented databases. This new deep learning technology, developed at the University of Cambridge, we analyse big, fragmented datasets, with a small number of well characterised records; typically created empirically at significant expense. Our new algorithm can extract an unprecedented amount of information, from datasets which are as little as 0.01% complete.
There are no Products & Services to display
18-02-2021
Machine learning technology will be used to make the additive manufacturing (AM) process of metallic alloys for aerospace cheaper and faster, encouraging the production of lightweight, energy-efficient aircraft to support net-zero targets for aviation.
14-01-2021
CAMBRIDGE, and MACCLESFIELD, UK, 3 December 2020 – The consortium behind the DeepADMET project set up to advance artificial intelligence (AI) technologies for drug discovery, today announced the successful conclusion of this project which was funded by Innovate UK, the UK’s innovation agency.
03-12-2020
Intellegens has received funding from Innovate UK to model COVID-19 data and improve the management of future coronavirus outbreaks and other infectious diseases. The tool, which will be based on Intellegens' unique deep-learning algorithm Alchemite™, will help understand how policy changes might impact outcomes, helping inform decision-making.
08-07-2020
Intellegens, AI company with unique deep learning toolset for sparse data, and Optibrium™, leading providers of software and services for drug discovery, today announced they have reached a further significant milestone in their contribution to the Open Source Malaria (OSM) initiative.
01-04-2020
A collaboration between the University of Cambridge, A*STAR and Nanyang Technological University in Singapore, assessed methods for predicting EV battery states and revealed that a data-driven machine learning model offers the most accurate predictions for state of charge and health.
02-03-2020
Intellegens, a Cambridge tech start-up with a unique Artificial Intelligence toolset that can train deep neural networks from sparse or noisy data, has been selected to be part of the ATI Boeing Accelerator programme.
19-12-2019
A collaboration between ANSYS Granta, Cambridge AI start-up Intellegens, and the University of Birmingham has secured funding from the Faraday Battery Challenge to optimise the battery manufacturing processes helping ensure the UK leads the world in the transition to a low carbon economy.
13-12-2019
Intellegens and Optibrium celebrate success in global challenge to find novel antimalarial compounds
Intellegens, an artificial intelligence (AI) start-up, and, Optibrium™, leading providers of software and services for drug discovery, have announced joint success in the Open Source Malaria (OSM) global initiative aimed at identifying the best predictive models for antimalarial compounds.
04-12-2019
Machine learning and artificial intelligence (AI) are transforming all aspects of daily life, but how can we use this powerful technology to search for new materials that will transform industries? The answer to this question will be addressed this week at The Advanced Materials Show 2019 by Dr Gareth Conduit, Chief Technology Officer at Intellegens - the Cambridge-based company with a unique...
08-07-2019
Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project.
20-09-2018
Using artificial intelligence (AI) and harnessing the power of deep learning to guide the design of new advanced materials, is the topic of a speaker paper that will be delivered at Engineering Materials Live later this week in Duxford.
18-09-2018
The potential of Intellegens’ Alchemite™ artificial intelligence (AI) technology has been demonstrated with a collaboration between the Cambridge-based company and e-Therapeutics; the Oxford-based pioneer of Network-Driven Drug Discovery (NDD).
05-02-2018
Intellegens, a new company spun out of the University of Cambridge to develop and commercialise novel artificial intelligence (AI) software, has received funding to help further develop its toolset.
06-12-2017
There are no events to display
20/04/2021
Dev-ops and Implementation Engineer
We are looking for a dev-ops and implementation engineer to work with our head of platform to deliver the software, and...
Location: Cambridge
Salary Range:
20/04/2021
Sales Executive
Intellegens is a spin-out from the University of Cambridge that has developed a unique machine learning platform that can...
Location: Cambridge
Salary Range:
No Blog articles found
